tiprankstipranks
Advertisement
Advertisement
Ideaya Biosciences enrolls first patient in IDE892 trial
PremiumThe FlyIdeaya Biosciences enrolls first patient in IDE892 trial
23d ago
IDEAYA Biosciences Raises $324 Million in Equity Offering
Premium
Company Announcements
IDEAYA Biosciences Raises $324 Million in Equity Offering
27d ago
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
Premium
The Fly
Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00
29d ago
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
PremiumCompany AnnouncementsIDEAYA, Roche launch PRMT5 and pan-RAS collaboration
1M ago
Ideaya Biosciences announces IDE892 collaboration with Roche
Premium
The Fly
Ideaya Biosciences announces IDE892 collaboration with Roche
1M ago
IDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
Premium
Company Announcements
IDEAYA Highlights Positive Phase 2/3 Darovasertib Trial Results
1M ago
IDEAYA Biosciences Files New Shelf Registration Statement
PremiumCompany AnnouncementsIDEAYA Biosciences Files New Shelf Registration Statement
2M ago
Ideaya Biosciences reports Q1 EPS ($1.11), consensus (98c)
Premium
The Fly
Ideaya Biosciences reports Q1 EPS ($1.11), consensus (98c)
2M ago
Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA
Premium
The Fly
Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100